Market Tracker

11/27 1:05pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

29.95
Data as of Nov 26
 +0.42 / +1.42%
Today’s Change
15.64
Today|||52-Week Range
32.00
+19.85%
Year-to-Date

Today’s Trading

Previous close29.53
Today’s open29.66
Day’s range29.31 - 30.20
Volume1,124,904
Average volume (3 months)1,279,574
Market cap$3.0B
Dividend yield--
Data as of 3:59pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)-15.79%
Earnings growth (this year)-107.58%
Earnings growth (next 5 years)--
Revenue growth (last year)-76.67%
P/E ratioNM
Price/Sales1,870.76
Price/Book14.98

Competitors

 Today’s
change
Today’s
% change
AVNRAvanir Pharmaceutica...+0.55+3.80%
ICPTIntercept Pharmaceut...+1.25+0.84%
--Cosmo Pharmaceutical...-11.95-6.38%
MNKDMannkind Corp+0.06+0.97%
Data as of 4:00pm ET, 11/26/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$1.1M
Annual profit (last year)-$37.9M
Net profit margin-3,314.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
CAO
Uli Hacksell
Executive VP, Chief Financial &
Business Officer
Stephen R. Davis
Corporate headquarters
San Diego, California

Forecasts